As of November 2026 Abivax has a market cap of A$11.03 Billion. This makes Abivax the world's 2409th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 8th, 2026 the market cap of Abivax was reported to be: